As Georges Yared wrote this morning, Dell Inc.'s (NASDAQ: DELL) accounting irregularities are the least of its problems these days, but perhaps they are at the root of the company's problems. It seems that Dell is in a fully-mired slump on almost all fronts right now: its shares are stagnant (and have been for a while), its sales are down while competitor HP is growing, many of the exec staff has left recently (and much new blood has arrived), and the company has now found possible mischievous actions within its finance controls department. What a mess.
So, regarding the accounting mess currently underway in Round Rock, the company has delayed filing its latest 10-K with the SEC while it digs into further dirt piles within is accounting and financial areas to see just what the heck is going on in there. The "evidence of misconduct" sounds like old hat these days: someone (or more than one) in accounting is cooking the books somehow. Possibilities are abundant: Did someone inflate revenue by accounting for sales before they occurred? Did someone decide to toss GAAP aside while trying to make Dell meet quarterly numbers?
Are you a Dell shareholder? If so, your voice should be loud and clear here: things need to start making a turnaround and pretty quickly. It's true that Sarbanes-Oxley has been a resource hog for many companies recently (it almost has to be by definition), but at Dell, I guess it wasn't on the list of priorities as irregularities were hidden, buried and stashed in an oil furnace somewhere. Shareholders deserve more, and so does the share price which almost doesn't deserve to be where it is until things are cleaned up.
DELL shares just opened down nearly 2% to $22.93.
Last updated: February 13, 2012: 09:18 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
TheFlyOnTheWall.com Headlines
- Chesapeake Energy volatility flat at 42 into financial plan
- Gardner Denver shares attractive at current levels, says RBC Capital
- Parkway Properties completes purchase of Phoenix Asset
- Total Q4 results in-line with expectations, says Nomura
- Mattress Firm downgraded to Market Perform from Outperform at Raymond James
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
3-30-2007 @ 10:31AM
Sheldon L said...
Forget about Dell -- it's not worth it!....... http://www.bloggingstocks.com/2007/03/02/forget-about-dell-its-not-worth-it/....... and now factor in account turmoil...oh my gosh!